One-Shot radiation may ease cancer pain as well as multiple sessions
NCT ID NCT04068649
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a single, precise dose of radiation (SBRT) can relieve pain and improve quality of life in people with cancer that has spread, compared to the usual multiple sessions of standard radiation. About 1,500 participants with metastatic tumors causing symptoms will be randomly assigned to one of the two approaches. The goal is to see if the faster treatment works just as well with fewer side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- radiation therapy (SBRT or standard palliative radiation)
- What this could lead to
- If successful, this could show that a single, precise dose of radiation works as well or better than multiple standard doses for relieving pain and improving quality of life in people with metastatic cancer.
- What could go wrong
- This is a phase 2 trial, so results are still preliminary. The single-dose approach may not control pain as effectively for all patients, and there could be unknown side effects from the higher dose per session.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Good Samaritan Hospital
RECRUITINGWest Islip, New York, 11795, United States
-
Roswell Park Cancer Institute
RECRUITINGBuffalo, New York, 14263, United States
-
The Cancer Institute at St. Francis Hospital
RECRUITINGEast Hills, New York, 11548, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New antibody drug aims to turn immune cells against cancer
- Freezing cancer cells: could cryoablation boost immunotherapy?
- Gene-Targeted cancer therapy put to the test in major trial
- New study aims to ease agitated delirium in dying cancer patients
- Can a common antipsychotic combo calm delirium in dying cancer patients?
- Exercise plus steroid pill may fight cancer fatigue